- Home
- ITGR vs ALKS Comparison
ITGR vs ALKS Comparison
Compare ITGR & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITGR
- ALKS
- Stock Information
- Founded
- ITGR 1970
- ALKS 1987
- Country
- ITGR United States
- ALKS Ireland
- Employees
- ITGR N/A
- ALKS N/A
- Industry
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- ITGR Health Care
- ALKS Health Care
- Exchange
- ITGR Nasdaq
- ALKS Nasdaq
- Market Cap
- ITGR 4.1B
- ALKS 4.5B
- IPO Year
- ITGR 2000
- ALKS 1991
- Fundamental
- Price
- ITGR $121.38
- ALKS $27.67
- Analyst Decision
- ITGR Strong Buy
- ALKS Buy
- Analyst Count
- ITGR 10
- ALKS 12
- Target Price
- ITGR $145.90
- ALKS $38.55
- AVG Volume (30 Days)
- ITGR 751.3K
- ALKS 1.9M
- Earning Date
- ITGR 04-24-2025
- ALKS 05-01-2025
- Dividend Yield
- ITGR N/A
- ALKS N/A
- EPS Growth
- ITGR N/A
- ALKS 3.47
- EPS
- ITGR 2.18
- ALKS 2.17
- Revenue
- ITGR $1,746,192,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- ITGR $10.86
- ALKS N/A
- Revenue Next Year
- ITGR $7.15
- ALKS $4.38
- P/E Ratio
- ITGR $54.54
- ALKS $12.60
- Revenue Growth
- ITGR 6.95
- ALKS N/A
- 52 Week Low
- ITGR $104.93
- ALKS $22.90
- 52 Week High
- ITGR $146.36
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- ITGR 55.65
- ALKS 34.69
- Support Level
- ITGR $113.42
- ALKS $26.70
- Resistance Level
- ITGR $119.33
- ALKS $27.80
- Average True Range (ATR)
- ITGR 5.65
- ALKS 1.32
- MACD
- ITGR 1.08
- ALKS -0.03
- Stochastic Oscillator
- ITGR 78.24
- ALKS 36.82
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.